Design, synthesis and biological activity of novel donepezil derivatives bearing N -benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors
- 1 June 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 133, 184-196
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81274200, 81403175)
- Youth Talent Sail Plan from Shanghai Committee of Science and Technology (14YF1411300)
- Shanghai Municipal Commission of Health and Family Planning (20134Y053)
- Research Fund for the Docoral Program of Shanghai (13401900301)
- Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University (07010150001)
This publication has 39 references indexed in Scilit:
- Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important LigandsJournal of Medicinal Chemistry, 2012
- New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing PropertiesJournal of Medicinal Chemistry, 2012
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Synthesis of novel trans-stilbene derivatives and evaluation of their potent antioxidant and neuroprotective effectsEuropean Journal of Medicinal Chemistry, 2009
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- A Century of Alzheimer's DiseaseScience, 2006
- The histamine H3 receptor: from gene cloning to H3 receptor drugsNature Reviews Drug Discovery, 2005
- Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2001
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976